E. Ohman J:or Asset Management’s Maravai LifeSciences MRVI Stock Holding History

E. Ohman J:or Asset Management’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-257,751	Closed	-$1.4M	–	429
2024 Q4	$1.4M	Buy	257,751 +25,000	+11%	+$161K	0.03%	233
2024 Q3	$1.93M	Buy	232,751 +52,000	+29%	+$450K	0.05%	163
2024 Q2	$1.29M	Buy	180,751 +40,698	+29%	+$351K	0.03%	219
2024 Q1	$1.21M	Buy	+140,053	New	+$948K	0.03%	224

Other funds holding MRVI

GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return

1WCM

12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

MFS

Mirabella Financial Services London, United Kingdom $1.06B AUM 19.83% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

E. Ohman J:or Asset Management's MRVI Position: Q1 2025 in Review

E. Ohman J:or Asset Management sold out of Maravai LifeSciences (MRVI) in Q1 2025, closing a stake of 257,751 shares — an estimated $1.4M sold.

E. Ohman J:or Asset Management first reported a position in MRVI in Q1 2024 and held it in 4 quarters. The position peaked at $1.93M in Q3 2024. 184 funds tracked by Wall St. Rank hold MRVI as of Q1 2025.

E. Ohman J:or Asset Management reported no remaining Maravai LifeSciences position as of Q1 2025 after selling out during the quarter.
E. Ohman J:or Asset Management sold 257,751 Maravai LifeSciences shares in Q1 2025, an estimated $1.4M.
E. Ohman J:or Asset Management first reported a position in Maravai LifeSciences in Q1 2024 and held it in 4 quarters.
E. Ohman J:or Asset Management's Maravai LifeSciences position peaked at $1.93M in Q3 2024.
184 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2025.

Based on E. Ohman J:or Asset Management's 13F filing for Q1 2025, filed 11 Apr 2025.